MedPath

Optic Neuritis and Ganglion Cell Layer

Completed
Conditions
Optic Neuritis
Registration Number
NCT02864134
Lead Sponsor
CHU de Quebec-Universite Laval
Brief Summary

BACKGROUND AND OBJECTIVES: The recent expansion of the applications of optical coherence tomography (OCT) demonstrated a higher correlation between the analysis of ganglion cells and visual function, in comparison with the analysis of the nerve fiber layer for several diseases of the optic nerve. Atrophy of the ganglion cells tends to induce the visual function deficits. In the case of optic neuritis, inflammation of the optic nerve causes a deficit of visual function initially with low vision, color blindness and visual field. Secondary atrophy of ganglion cell can result. The purpose of the study is to evaluate the correlation between the analysis of ganglion cells at the time of diagnosis of optic neuritis and the resulting visual acuity at 6 months and visual function (visual acuity, color vision and perimetry) 1 year regardless of treatment. A predictive effect could help predict the patient's clinical course and management of uncertainty and anxiety. MATERIALS AND METHODS: An assessment at diagnosis and follow-ups at 6 months and 1 year with a measurement of best corrected visual acuity, a test color vision HRR (Hardy-Rand-Rittler), an OCT with analysis of ganglion cells and perimetry Humphrey 30 -2 fast will be done. Simple linear and logistic regressions will be used. RESULTS: We expect that there will be a significant association between atrophy of ganglion cells in the diagnosis and residual visual function after an episode of optic neuritis. We believe that the initial atrophy is associated with poorer visual prognosis. CONCLUSION: A predictive effect could help to inform the patient about the evolution of the disease and provide early visual rehabilitation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
25
Inclusion Criteria

Major and apt patients seen in consultation with diagnosis of optic neuritis

Exclusion Criteria
  • Concomitant ophthalmic diseases

    • known macular pathology
    • Amblyopia
    • Glaucoma
    • History of an ophthalmic surgery
    • Family history of hereditary optic neuropathy
    • Pathological myopia (refractive error of 8 diopters or more).
  • Known neurological disease other than multiple sclerosis.

  • Habit

    • Nutritional deficiency anorexia, restrictive gastrointestinal surgery.
  • Active or former professional or recreational exposure

    • Exposure to metals: lead, mercury, thallium
    • Exposure to solvents: ethylene glycol, toluene, styrene, perchlorethylene;
    • Prior poisoning: methanol, carbon dioxide.
  • Usual or earlier Medication

    • Taking one or more drugs known to cause toxic optic neuropathy*

      • listed available on demand

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Association between the analysis of ganglion cells at diagnosis and the visual function at 12 months after optic neuritis12 months post optic neuritis

Evaluation of the visual function (best corrected visual acuity, perimetry, color vision) at 12 months post optic neuritis episode in correlation with initial ganglion cell layer analysis measures in order to predict the visual acuity in the future.

Association between the analysis of ganglion cells at diagnosis and the resulting visual acuity at 6 months after optic neuritis6 months post optic neuritis

Evaluation of best corrected visual acuity at 6 months post optic neuritis episode in correlation with initial ganglion cell layer analysis measures in order to predict the visual acuity in the future.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hopital Saint-Sacrement

🇨🇦

Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath